drugset / Trial / NCT03801876

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

NCT03801876 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

This trial studies how well proton beam radiation therapy compared with intensity modulated photon radiotherapy works in treating patients with stage I-IVA esophageal cancer. Proton beam radiation therapy uses a beam of protons (rather than x-rays) to send radiation inside the body to the tumor without damaging much of the healthy tissue around it. Intensity modulated photon radiotherapy uses high-energy x-rays to deliver radiation directly to the tumor without damaging much of the healthy tissue around it. It is not yet known whether proton beam therapy or intensity modulated photon radiotherapy will work better in treating patients with esophageal cancer.

Timeline

Start
2019-06-26
Primary completion
2026-12-21
Completion
2031-12-21

Drugs

EvaluationDrugModalityDoseRoute
Background Capecitabine Small molecule — Oral
Background Carboplatin Small molecule — Intravenous
Background Docetaxel Small molecule — —
Background Leucovorin Small molecule — Oral
Background Oxaliplatin Small molecule — —
Background Paclitaxel Small molecule — Intravenous
Background fluorouracil Small molecule — —